MENU
AMLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Amylyx Pharmaceuticals (AMLX) Earnings Date & Reports

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases... Show more

A.I. Advisor
published Earnings

AMLX is expected to report earnings to rise 5.08% to -38 cents per share on April 01

Amylyx Pharmaceuticals AMLX Stock Earnings Reports
Q4'25
Est.
$-0.39
Q3'25
Beat
by $0.08
Q2'25
Est.
$-0.46
Q1'25
Beat
by $0.20
Q4'24
Beat
by $0.01
The last earnings report on November 06 showed earnings per share of -37 cents, beating the estimate of -44 cents. With 1.05M shares outstanding, the current market capitalization sits at 1.36B.
View a ticker or compare two or three
AMLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AMLX showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
43 Thorndike Street
Phone
+1 617 682-0917
Employees
384
Web
https://www.amylyx.com